mirvetuximab
immunogen
['mirasol']
and just like that the patients and the investigators changed the standard of care in platinum resistant ovary cancer through the results of mirasol presented this morning by kathleen moore at #asco23. longer survival , less toxicity, abd better quality of life. 
Professor of OB/GYN at Sidney Kimmel Medical College of Thomas Jefferson University, Gynecologic Oncologist fighting cancer everyday. proud father, Husband.